Studies on the Q175 knock-in model of Huntington's disease using functional imaging in awake mice: Evidence of olfactory dysfunction

Frontiers in Neurology

Volumn 5 JUN, Issue , 2014, Pages

  Ferris, Craig F ^a   Kulkarni, Praveen ^a   Toddes, Steven ^b   Yee, Jason ^a   Kenkel, William ^a   Nedelman, Mark ^c  

^a NORTHEASTERN UNIVERSITY   (United States)

^b Animal Imaging Research   (United States)

^c Ekam Imaging   (United States)

Author keywords

Awake animal imaging; BOLD FMRI; Feeding behavior; Huntingtin associated protein 1; Mouse model of huntington's disease; Neural pathways; Reward processing

Indexed keywords

HUNTINGTIN;

ALMOND; ANIMAL EXPERIMENT; ANIMAL IMAGING SYSTEM; ANIMAL MODEL; ANTERIOR CINGULATE; ARTICLE; BOLD SIGNAL; CAUDATE NUCLEUS; CONTROLLED STUDY; DENTATE GYRUS; EMOTION; FEMALE; FOREBRAIN; FUNCTIONAL NEUROIMAGING; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; HUNTINGTIN GENE; HUNTINGTON CHOREA; HYPOTHALAMUS; MALE; MOTIVATION; MOUSE; MOUSE MODEL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUT; OLFACTORY BULB; PUTAMEN; SMELLING DISORDER; SUBICULUM; THALAMUS;

EID: 84904412773     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2014.00094     Document Type: Article

References (71)

1. Montoya A, Pelletier M, Menear M, Duplessis E, Richer F, Lepage M. Episodic memory impairment in Huntington's disease: a meta-analysis. Neuropsychologia (2006) 44(10):1984-94. doi: 10.1016/j.neuropsychologia.2006.01.015
2. Montoya A, Price BH, Menear M, Lepage M. Brain imaging and cognitive dysfunctions in Huntington's disease. J Psychiatry Neurosci (2006) 31(1):21-9
3. Rosenblatt A, Leroi I. Neuropsychiatry of Huntington's disease and other basal ganglia disorders. Psychosomatics (2000) 41(1):24-30. doi:10.1016/S0033-3182(00)71170-4
4. Enzi B, Edel MA, Lissek S, Peters S, Hoffmann R, Nicolas V, et al. Altered ventral striatal activation during reward and punishment processing in premanifest Huntington's disease: a functional magnetic resonance study. Exp Neurol (2012) 235(1):256-64. doi:10.1016/j.expneurol.2012.02.003
5. Ferris CF, Smerkers B, Kulkarni P, Caffrey M, Afacan O, Toddes S, et al. Functional magnetic resonance imaging in awake animals. Rev Neurosci (2011) 22(6):665-74. doi:10.1515/RNS.2011.050
6. Menalled LB, Kudwa AE, Miller S, Fitzpatrick J, Watson-Johnson J, Keating N, et al. Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington's disease: zQ175. PLoS One (2012) 7(12):e49838. doi:10.1371/journal.pone.0049838
7. Heikkinen T, Lehtimaki K, Vartiainen N, Puolivali J, Hendricks SJ, Glaser JR, et al. Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington's disease. PLoS One (2012) 7(12):e50717. doi:10.1371/journal.pone.0050717
8. Heng MY, Tallaksen-Greene SJ, Detloff PJ, Albin RL. Longitudinal evaluation of the Hdh(CAG)150 knock-in murine model of Huntington's disease. J Neurosci (2007) 27(34):8989-98. doi:10.1523/JNEUROSCI.1830-07.2007
9. Heng MY, Detloff PJ, Paulson HL, Albin RL. Early alterations of autophagy in Huntington disease-like mice. Autophagy (2010) 6(8):1206-8. doi:10.4161/auto.6.8.13617
10. Kulkarni P, Stolberg T, Sullivanjr JM, Ferris CF. Imaging evolutionarily conserved neural networks: preferential activation of the olfactory system by food-related odor. Behav Brain Res (2012) 230(1):201-7. doi:10.1016/j.bbr.2012.02.002
11. Desai M, Kahn I, Knoblich U, Bernstein J, Atallah H, Yang A, et al. Mapping brain networks in awake mice using combined optical neural control and fMRI. J Neurophysiol (2011) 105(3):1393-405. doi:10.1152/jn.00828.2010
12. King JA, Garelick TS, Brevard ME, Chen W, Messenger TL, Duong TQ, et al. Procedure for minimizing stress for fMRI studies in conscious rats. J Neurosci Methods (2005) 148(2):154-60. doi:10.1016/j.jneumeth.2005.04.011
13. Norris DG. Principles of magnetic resonance assessment of brain function. J Magn Reson Imaging (2006) 23(6):794-807. doi:10.1002/jmri.20587
14. Duong TQ, Yacoub E, Adriany G, Hu X, Ugurbil K, Kim SG. Microvascular BOLD contribution at 4 and 7 T in the human brain: gradient-echo and spin-echo fMRI with suppression of blood effects. Magn Reson Med (2003) 49(6):1019-27. doi:10.1002/mrm.10472
15. Yacoub E, Shmuel A, Logothetis N, Ugurbil K. Robust detection of ocular dominance columns in humans using Hahn spin echo BOLD functional MRI at 7 Tesla. Neuroimage (2007) 37(4):1161-77. doi:10.1016/j.neuroimage.2007.05.020
16. Zhang N, Yacoub E, Zhu XH, Ugurbil K, Chen W. Linearity of blood-oxygenation-level dependent signal at microvasculature. Neuroimage (2009) 48(2):313-8. doi:10.1016/j.neuroimage.2009.06.071
17. Brevard ME, Duong TQ, King JA, Ferris CF. Changes in MRI signal intensity during hypercapnic challenge under conscious and anesthetized conditions. Magn Reson Imaging (2003) 21(9):995-1001. doi:10.1016/S0730-725X(03)00204-2
18. Genovese CR, Lazar NA, Nichols T. Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage (2002) 15:870-8. doi:10.1006/nimg.2001.1037
19. Jacobson A, Green E, Murphy C. Age-related functional changes in gustatory and reward processing regions: an fMRI study. Neuroimage (2010) 53(2):602-10. doi:10.1016/j.neuroimage.2010.05.012
20. Grabenhorst F, Rolls ET, Parris BA, d'Souza AA. How the brain represents the reward value of fat in the mouth. Cereb Cortex (2010) 20(5):1082-91. doi:10.1093/cercor/bhp169
21. Bragulat V, Dzemidzic M, Bruno C, Cox CA, Talavage T, Considine RV, et al. Food-related odor probes of brain reward circuits during hunger: a pilot fMRI study. Obesity (Silver Spring) (2010) 18(8):1566-71. doi:10.1038/oby.2010.57
22. McCabe C, Rolls ET. Umami: a delicious flavor formed by convergence of taste and olfactory pathways in the human brain. Eur J Neurosci (2007) 25(6):1855-64. doi:10.1111/j.1460-9568.2007.05445.x
23. Nordin S, Paulsen JS, Murphy C. Sensory- and memory-mediated olfactory dysfunction in Huntington's disease. J Int Neuropsychol Soc (1995) 1(3):281-90. doi:10.1017/S1355617700000278
24. Lazic SE, Goodman AO, Grote HE, Blakemore C, Morton AJ, Hannan AJ, et al. Olfactory abnormalities in Huntington's disease: decreased plasticity in the primary olfactory cortex of R6/1 transgenic mice and reduced olfactory discrimination in patients. Brain Res (2007) 1151:219-26. doi:10.1016/j.brainres.2007.03.018
25. Hamilton JM, Murphy C, Paulsen JS. Odor detection, learning, and memory in Huntington's disease. J Int Neuropsychol Soc (1999) 5(7):609-15. doi:10.1017/S1355617799577035
26. Moberg PJ, Doty RL. Olfactory function in Huntington's disease patients and at-risk offspring. Int J Neurosci (1997) 89(1-2):133-9. doi:10.3109/00207459708988468
27. Larsson M, Lundin A, Robins Wahlin TB. Olfactory functions in asymptomatic carriers of the Huntington disease mutation. J Clin Exp Neuropsychol (2006) 28(8):1373-80. doi:10.1080/13803390500473746
28. Pirogovsky E, Gilbert PE, Jacobson M, Peavy G, Wetter S, Goldstein J, et al. Impairments in source memory for olfactory and visual stimuli in preclinical and clinical stages of Huntington's disease. J Clin Exp Neuropsychol (2007) 29(4):395-404. doi:10.1080/13803390600726829
29. Menalled LB, Sison JD, Dragatsis I, Zeitlin S, Chesselet MF. Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats. J Comp Neurol (2003) 465(1):11-26. doi:10.1002/cne.10776
30. Cepeda-Prado E, Popp S, Khan U, Stefanov D, Rodriguez J, Menalled LB, et al. R6/2 Huntington's disease mice develop early and progressive abnormal brain metabolism and seizures. J Neurosci (2012) 32(19):6456-67. doi:10.1523/JNEUROSCI.0388-12.2012
31. Paulsen JS, Wang C, Duff K, Barker R, Nance M, Beglinger L, et al. Challenges assessing clinical endpoints in early Huntington disease. Mov Disord (2010) 25(15):2595-603. doi:10.1002/mds.23337
32. Beglinger LJ, O'Rourke JJ, Wang C, Langbehn DR, Duff K, Paulsen JS. Earliest functional declines in Huntington disease. Psychiatry Res (2010) 178(2):414-8. doi:10.1016/j.psychres.2010.04.030
33. Duff K, Paulsen J, Mills J, Beglinger LJ, Moser DJ, Smith MM, et al. Mild cognitive impairment in prediagnosed Huntington disease. Neurology (2010) 75(6):500-7. doi:10.1212/WNL.0b013e3181eccfa2
34. Paulsen JS, Smith MM, Long JD. Cognitive decline in prodromal Huntington disease: implications for clinical trials. J Neurol Neurosurg Psychiatry (2013) 84(11):1233-9. doi:10.1136/jnnp-2013-305114
35. Fielding SA, Brooks SP, Klein A, Bayram-Weston Z, Jones L, Dunnett SB. Profiles of motor and cognitive impairment in the transgenic rat model of Huntington's disease. Brain Res Bull (2012) 88(2-3):223-36. doi:10.1016/j.brainresbull.2011.09.011
36. Bayram-Weston Z, Jones L, Dunnett SB, Brooks SP. Light and electron microscopic characterization of the evolution of cellular pathology in YAC128 Huntington's disease transgenic mice. Brain Res Bull (2012) 88(2-3):137-47. doi:10.1016/j.brainresbull.2011.05.005
37. Brooks SP, Betteridge H, Trueman RC, Jones L, Dunnett SB. Selective extra-dimensional set shifting deficit in a knock-in mouse model of Huntington's disease. Brain Res Bull (2006) 69(4):452-7. doi:10.1016/j.brainresbull.2006.02.011
38. Lione LA, Carter RJ, Hunt MJ, Bates GP, Morton AJ, Dunnett SB. Selective discrimination learning impairments in mice expressing the human Huntington's disease mutation. J Neurosci (1999) 19(23):10428-37
39. Sif J, Messier C, Meunier M, Bontempi B, Calas A, Destrade C. Time-dependent sequential increases in [14C]2-deoxyglucose uptake in subcortical and cortical structures during memory consolidation of an operant training in mice. Behav Neural Biol (1991) 56(1):43-61. doi:10.1016/0163-1047(91)90279-Y
40. Ransome MI, Hannan AJ. Behavioural state differentially engages septohippocampal cholinergic and GABAergic neurons in R6/1 Huntington's disease mice. Neurobiol Learn Mem (2012) 97(2):261-70. doi:10.1016/j.nlm.2012.01.004
41. Murmu RP, Li W, Holtmaat A, Li JY. Dendritic spine instability leads to progressive neocortical spine loss in a mouse model of Huntington's disease. J Neurosci (2013) 33(32):12997-3009. doi:10.1523/JNEUROSCI.5284-12.2013
42. Cummings DM, Andre VM, Uzgil BO, Gee SM, Fisher YE, Cepeda C, et al. Alterations in cortical excitation and inhibition in genetic mouse models of Huntington's disease. J Neurosci (2009) 29(33):10371-86. doi:10.1523/JNEUROSCI.1592-09.2009
43. Joshi PR, Wu NP, Andre VM, Cummings DM, Cepeda C, Joyce JA, et al. Age-dependent alterations of corticostriatal activity in the YAC128 mouse model of Huntington disease. J Neurosci (2009) 29(8):2414-27. doi:10.1523/JNEUROSCI.5687-08.2009
44. Rosas HD, Koroshetz WJ, Chen YI, Skeuse C, Vangel M, Cudkowicz ME, et al. Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis. Neurology (2003) 60(10):1615-20. doi:10.1212/01.WNL.0000065888.88988.6E
45. Aylward EH, Anderson NB, Bylsma FW, Wagster MV, Barta PE, Sherr M, et al. Frontal lobe volume in patients with Huntington's disease. Neurology (1998) 50(1):252-8. doi:10.1212/WNL.50.1.252
46. Bohanna I, Georgiou-Karistianis N, Hannan AJ, Egan GF. Magnetic resonance imaging as an approach towards identifying neuropathological biomarkers for Huntington's disease. Brain Res Rev (2008) 58(1):209-25. doi:10.1016/j.brainresrev.2008.04.001
47. Lerch JP, Carroll JB, Spring S, Bertram LN, Schwab C, Hayden MR, et al. Automated deformation analysis in the YAC128 Huntington disease mouse model. Neuroimage (2008) 39(1):32-9. doi:10.1016/j.neuroimage.2007.08.033
48. Sawiak SJ, Wood NI, Williams GB, Morton AJ, Carpenter TA. Voxel-based morphometry in the R6/2 transgenic mouse reveals differences between genotypes not seen with manual 2D morphometry. Neurobiol Dis (2009) 33(1):20-7. doi:10.1016/j.nbd.2008.09.016
49. Rattray I, Smith EJ, Crum WR, Walker TA, Gale R, Bates GP, et al. Correlations of behavioral deficits with brain pathology assessed through longitudinal MRI and histopathology in the R6/1 mouse model of Huntington's disease. PLoS One (2013) 8(12):e84726. doi:10.1371/journal.pone.0084726
50. Fujinaga R, Kawano J, Matsuzaki Y, Kamei K, Yanai A, Sheng Z, et al. Neuroanatomical distribution of huntingtin-associated protein 1-mRNA in the male mouse brain. J Comp Neurol (2004) 478(1):88-109. doi:10.1002/cne.20277
51. Wong YC, Holzbaur EL. The regulation of autophagosome dynamics by huntingtin and HAP1 is disrupted by expression of mutant huntingtin, leading to defective cargo degradation. J Neurosci (2014) 34(4):1293-305. doi:10.1523/JNEUROSCI.1870-13.2014
52. Bertaux F, Sharp AH, Ross CA, Lehrach H, Bates GP, Wanker E. HAP1-huntingtin interactions do not contribute to the molecular pathology in Huntington's disease transgenic mice. FEBS Lett (1998) 426(2):229-32. doi:10.1016/S0014-5793(98)00352-4
53. Chan EY, Nasir J, Gutekunst CA, Coleman S, Maclean A, Maas A, et al. Targeted disruption of huntingtin-associated protein-1 (Hap1) results in postnatal death due to depressed feeding behavior. Hum Mol Genet (2002) 11(8):945-59. doi:10.1093/hmg/11.8.945
54. Li SH, Yu ZX, Li CL, Nguyen HP, Zhou YX, Deng C, et al. Lack of huntingtin-associated protein-1 causes neuronal death resembling hypothalamic degeneration in Huntington's disease. J Neurosci (2003) 23(17):6956-64
55. Xiang J, Yang H, Zhao T, Sun M, Xu X, Zhou XF, et al. Huntingtin-associated protein 1 regulates postnatal neurogenesis and neurotrophin receptor sorting. J Clin Invest (2014) 124(1):85-98. doi:10.1172/JCI69206
56. Lin YF, Xu X, Cape A, Li S, Li XJ. Huntingtin-associated protein-1 deficiency in orexin-producing neurons impairs neuronal process extension and leads to abnormal behavior in mice. J Biol Chem (2010) 285(21):15941-9. doi:10.1074/jbc.M110.107318
57. Yang M, Lim Y, Li X, Zhong JH, Zhou XF. Precursor of brain-derived neurotrophic factor (proBDNF) forms a complex with huntingtin-associated protein-1 (HAP1) and sortilin that modulates proBDNF trafficking, degradation, and processing. J Biol Chem (2011) 286(18):16272-84. doi:10.1074/jbc.M110.195347
58. Wu LL, Fan Y, Li S, Li XJ, Zhou XF. Huntingtin-associated protein-1 interacts with pro-brain-derived neurotrophic factor and mediates its transport and release. J Biol Chem (2010) 285(8):5614-23. doi:10.1074/jbc.M109.073197
59. Li Y, Chin LS, Levey AI, Li L. Huntingtin-associated protein 1 interacts with hepatocyte growth factor-regulated tyrosine kinase substrate and functions in endosomal trafficking. J Biol Chem (2002) 277(31):28212-21. doi:10.1074/jbc.M111612200
60. Kittler JT, Thomas P, Tretter V, Bogdanov YD, Haucke V, Smart TG, et al. Huntingtin-associated protein 1 regulates inhibitory synaptic transmission by modulating gamma-aminobutyric acid type A receptor membrane trafficking. Proc Natl Acad Sci U S A (2004) 101(34):12736-41. doi:10.1073/pnas.0401860101
61. Sheng G, Chang GQ, Lin JY, Yu ZX, Fang ZH, Rong J, et al. Hypothalamic huntingtin-associated protein 1 as a mediator of feeding behavior. Nat Med (2006) 12(5):526-33. doi:10.1038/nm1382
62. Zhang Z, Andersen AH, Avison MJ, Gerhardt GA, Gash DM. Functional MRI of apomorphine activation of the basal ganglia in awake rhesus monkeys. Brain Res (2000) 852(2):290-6. doi:10.1016/S0006-8993(99)02243-X
63. Ferris CF, Snowdon CT, King JA, Sullivan JM Jr, Ziegler TE, Olson DP, et al. Activation of neural pathways associated with sexual arousal in non-human primates. J Magn Reson Imaging (2004) 19(2):168-75. doi:10.1002/jmri.10456
64. Tenney JR, Duong TQ, King JA, Ludwig R, Ferris CF. Corticothalamic modulation during absence seizures: a functional MRI approach. Epilepsia (2003) 44:1133-40. doi:10.1046/j.1528-1157.2003.61002.x
65. Tenney JR, Brevard ME, King JA, Ferris CF. fMRI of generalized absence seizures in conscious marmoset monkeys reveals corticothalamic activation. Epilepsia (2004) 45:1240-7. doi:10.1111/j.0013-9580.2004.21504.x
66. Febo M, Segarra A, Nair G, Schmidt K, Duong T, Ferris C. The neural consequences of repeated cocaine exposure revealed by functional MRI in awake rats. Neuropsychopharmacology (2005) 25:1132-6
67. Ferris CF, Kulkarni P, Sullivan MJJ, Harder JA, Messenger TL, Febo M. Pup suckling is more rewarding than cocaine: evidence from fMRI and 3D computational analyses. J Neurosci (2005) 25:149-56. doi:10.1523/JNEUROSCI.3156-04.2005
68. Febo M, Segarra AC, Tenney JR, Sullivan R, Brevard M, Duong TQ, et al. Imaging cocaine-induced changes in the reward system in conscous rate. J Neurosci Methods (2004) 139:167-76. doi:10.1016/j.jneumeth.2004.04.028
69. Skoubis PD, Hradil VP, Chin CL, Luo Y, Fox GB, McGaraughty S. Mapping brain activity following administration of a nicotinic acetylcholine receptor agonist, ABY-594, using functional magnetic resonance imaging in awake rats. Neuroscience (2006) 137:583-91. doi:10.1016/j.neuroscience.2005.08.072
70. Chin CL, Fox GB, Hradil VP, Osinski MA, McGaraughty SP, Skoubis PD, et al. Pharmacological MRI in awake rats reveals neural activity in area postrema and nucleus tractus solitarius: relevance as a potential biomarker for detecting drug-induced emesis. Neuroimage (2006) 33:1152-60. doi:10.1016/j.neuroimage.2006.06.059
71. Hariri AR, Drabant EM, Weinberger DR. Imaging genetics: perspectives from studies of genetically driven variation in serotonin function and corticolimbic affective processing. Biol Psychiatry (2006) 59(10):888-97. doi:10.1016/j.biopsych.2005.11.005